Atlantic Health System Cancer Care First to Begin Clinical Trial for Late-Stage Melanoma of Novel Virus-Based Immunotherapy

August 1, 2017

MORRISTOWN, NJ  – Atlantic Health System Cancer Care is the first oncology institution in the world to sign on to, and to enroll the first patient in, a multicenter Phase IIa clinical trial of OBP-301 (Telomelysin), a virus-based immunotherapy for late-stage melanoma that has not responded to other treatments. 

This leading-edge experimental therapy, which is under ...

Atlantic Health System CEO Gragnolati Named Chair-Elect by American Hospital Association

SAN DIEGO, CA— The American Hospital Association’s (AHA) Board of Trustees has selected Brian Gragnolati, president and CEO of Atlantic Health System, as its chair-elect designate. Gragnolati will assume the chairmanship in 2019, becoming the top-elected official of the national organization that represents America’s hospitals and health systems and works to advance health in ...

Atlantic Health System Cancer Care Offers Ovarian Cancer Screening Study

MORRISTOWN, NJ - When treated in its earliest stages, the five-year survival rate for ovarian cancer is more than 90 percent. Unfortunately, only 15 percent of cases are found at this early stage due to ovarian cancer's non-specific symptoms and lack of available early detection tests.

When discovered at a more advanced stage, the ovarian cancer survival rate can be as low as 18 ...

TAP Into Another Town's News:

TAP Into Another Town's News:

Sign Up for E-News